We are live on ! Find out more
HC

Henshaw Capital Portfolio holdings

AUM $3.07B
1-Year Est. Return 40.85%
This Fund
S&P 500
This Quarter Est. Return
-13.93%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$1.44B
AUM Growth
-$266M
Cap. Flow
-$4.59M
Cap. Flow %
-0.32%
Top 10 Hldgs %
33.34%
Holding
325
New
10
Increased
75
Reduced
47
Closed
24

Top Buys

Rank Stock Value
1
BURL icon
Burlington
BURL
+$598K
2
TFX icon
Teleflex
TFX
+$547K
3
GDDY icon
GoDaddy
GDDY
+$471K
4
BMY icon
Bristol-Myers Squibb
BMY
+$452K
5
XMTR icon
Xometry
XMTR
+$416K

Top Sells

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$999K
2
C icon
Citigroup
C
+$675K
3
WRB icon
W.R. Berkley
WRB
+$655K
4
CSL icon
Carlisle Companies
CSL
+$506K
5
WSC icon
WillScot Mobile Mini Holdings
WSC
+$502K

Sector Composition

Rank Sector Weight
1 Technology 24.14%
2 Industrials 16.41%
3 Healthcare 12.77%
4 Financials 11.85%
5 Communication Services 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BUR icon
226
Burford Capital
BUR
$957M
$293K 0.02%
28,994
– –
HLNE icon
227
Hamilton Lane
HLNE
$4.6B
$291K 0.02%
4,337
+1,144
+36% +$78.8K
CNMD icon
228
CONMED
CNMD
$1.5B
$289K 0.02%
3,023
– –
LGND icon
229
Ligand Pharmaceuticals
LGND
$5.59B
$288K 0.02%
5,171
– –
MBUU icon
230
Malibu Boats
MBUU
$538M
$287K 0.02%
5,448
– –
MXL icon
231
MaxLinear
MXL
$5.6B
$286K 0.02%
8,421
– –
COF icon
232
Capital One
COF
$132B
$281K 0.02%
2,695
+252
+10% +$30.8K
INSP icon
233
Inspire Medical Systems
INSP
$1.78B
$281K 0.02%
1,537
– –
CP icon
234
Canadian Pacific Kansas City
CP
$82.7B
$278K 0.02%
3,977
– –
SMTC icon
235
Semtech
SMTC
$12.2B
$276K 0.02%
5,023
+912
+22% +$55K
AMRC icon
236
Ameresco
AMRC
$1.17B
$275K 0.02%
6,037
– –
KALU icon
237
Kaiser Aluminum
KALU
$2.56B
$273K 0.02%
3,451
– –
TMHC
238
DELISTED
Taylor Morrison
TMHC
$273K 0.02%
11,680
– –
NWE icon
239
NorthWestern Energy
NWE
$4.33B
$273K 0.02%
4,627
– –
INDB icon
240
Independent Bank
INDB
$3.89B
$272K 0.02%
3,430
– –
PH icon
241
Parker-Hannifin
PH
$125B
$272K 0.02%
1,104
– –
RARE icon
242
Ultragenyx Pharmaceutical
RARE
$2.52B
$269K 0.02%
4,512
+628
+16% +$38.6K
VRNS icon
243
Varonis Systems
VRNS
$5.04B
$269K 0.02%
9,175
+3,447
+60% +$128K
VLY icon
244
Valley National Bancorp
VLY
$7.69B
$263K 0.02%
25,219
– –
CAE icon
245
CAE Inc
CAE
$7.81B
$260K 0.02%
10,556
– –
ZTS icon
246
Zoetis
ZTS
$32B
$260K 0.02%
1,510
-464
-24% -$80.2K
MRVL icon
247
Marvell Technology
MRVL
$195B
$259K 0.02%
5,948
-957
-14% -$54.2K
SUPN icon
248
Supernus Pharmaceuticals
SUPN
$2.54B
$258K 0.02%
8,921
– –
NUVA
249
DELISTED
NuVasive, Inc.
NUVA
$258K 0.02%
5,247
– –
ABB
250
DELISTED
ABB Ltd
ABB
$257K 0.02%
9,632
-1,067
-10% -$31.7K
8 9
10
11 12

Similar funds

DMIC
Dixon Mitchell Investment Counsel Vancouver, British Columbia, Canada $3.07B AUM 16.75% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $3.08B AUM 27.39% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
CI
Capital International Los Angeles, California $3.06B AUM 33.84% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $3.06B AUM 26.31% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Henshaw Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Henshaw Capital held 325 positions worth $1.44B, down 16% from $1.71B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Henshaw Capital's Q2 2022 filing shows 10 new, 75 increased, 47 reduced and 24 closed positions. Its largest new stake was Bristol-Myers Squibb: 5,930 shares worth $457K. The largest sale was Dentsply Sirona, an estimated $999K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Industrials and Healthcare.

  • Henshaw Capital's largest Q2 2022 buy was Bristol-Myers Squibb: 5,930 shares worth $457K.
  • Henshaw Capital added most to Burlington in Q2 2022, an estimated $598K increase.
  • Henshaw Capital's biggest Q2 2022 reduction was Citigroup, cutting an estimated $675K.
  • Henshaw Capital fully exited Dentsply Sirona in Q2 2022, selling an estimated $999K.
  • Henshaw Capital's ten largest holdings make up 33% of its $1.44B portfolio in Q2 2022.
  • Henshaw Capital opened 10 new positions and closed 24 in Q2 2022.
  • Henshaw Capital's portfolio value fell 16% quarter-over-quarter to $1.44B.

Based on Henshaw Capital's 13F filing for Q2 2022, filed 28 May 2026.